Clinical trial
Esophageal Squamous Cell Carcinoma African Prevention Research (ESCCAPE) Cytosponge™ Feasibility Study
NCT04090554 is registered in ClinicalTrials.gov with International Agency for Research on Cancer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Esophageal Squamous Cell Carcinoma African Prevention Research (ESCCAPE) Cytosponge™ Feasibility Study
- Lead sponsor
- International Agency for Research on Cancer
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 24, 2019
- Completion date
- December 30, 2020
- Enrollment
- 101 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal diseases, esophagus scc